Deregulation of the PI3K and KRAS signaling pathways in human cancer cells determines their response to everolimus-Reference-Cited by-同舟云学术

Deregulation of the PI3K and KRAS signaling pathways in human cancer cells determines their response to everolimus

Published:2010-08-02 Issue:8 Volume:120 Page:2858-2866
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Di Nicolantonio Federica,Arena Sabrina,Tabernero Josep,Grosso Stefano,Molinari Francesca,Macarulla Teresa,Russo Mariangela,Cancelliere Carlotta,Zecchin Davide,Mazzucchelli Luca,Sasazuki Takehiko,Shirasawa Senji,Geuna Massimo,Frattini Milo,Baselga José,Gallicchio Margherita,Biffo Stefano,Bardelli Alberto

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference38 articles.

1. Mutations in a signalling pathway

2. Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery

3. Novel Agents on the Horizon for Cancer Therapy

4. Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma

5. Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial

Cited by 313 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In silico Exploration of a Novel ICMT Inhibitor with More Solubility than Cysmethynil against Membrane Localization of KRAS Mutant in Colorectal Cancer;Current Computer-Aided Drug Design;2024-12

2. The Role of the PI3K/Akt/mTOR Axis in Head and Neck Squamous Cell Carcinoma;Biomedicines;2024-07-19

3. KRAS Mutation Subtypes and Their Association with Other Driver Mutations in Oncogenic Pathways;Cells;2024-07-19

4. The mitochondria-related gene risk mode revealed p66Shc as a prognostic mitochondria-related gene of glioblastoma;Scientific Reports;2024-05-19

5. Distinct Driver Pathway Enrichments and a High Prevalence of TSC2 Mutations in Right Colon Cancer in Chile: A Preliminary Comparative Analysis;International Journal of Molecular Sciences;2024-04-25